ID   KE 37.3.2
AC   CVCL_L699
SY   KE37.3.2; KE37 3.2
DR   cancercelllines; CVCL_L699
DR   Wikidata; Q54899711
RX   PubMed=6983562;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Gln2459Ter (c.7375C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9585; PTCH1; Simple; p.Arg571Gln (c.1712G>A); ClinVar=VCV000819886; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9884; RB1; Simple; p.Gly310Glu (c.929G>A); ClinVar=VCV000237678; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1327 ! KE-37
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 05-10-23; Version: 14
//
RX   PubMed=6983562; DOI=10.1084/jem.156.6.1860;
RA   Mayer L., Fu S.-M., Kunkel H.G.;
RT   "Human T cell hybridomas secreting factors for IgA-specific help,
RT   polyclonal B cell activation, and B cell proliferation.";
RL   J. Exp. Med. 156:1860-1865(1982).
//